CJC-1295 with DAC: The Long-Acting Growth Hormone Releasing Peptide Explained

When researchers need to study sustained growth hormone (GH) elevation over an extended period, CJC-1295 with DAC has become one of their most reliable tools. Its unusually long half-life sets it apart from most other growth hormone secretagogues and makes it a unique subject of study in endocrine and metabolic research.

All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use.

What Is CJC-1295 with DAC?

CJC-1295 is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) — the hypothalamic hormone that signals the pituitary gland to produce and release growth hormone. On its own, CJC-1295 would have a relatively short effective duration, like most peptides. But the addition of DAC — Drug Affinity Complex — changes that picture dramatically.

DAC is a technology that allows the peptide to bind to albumin, the most abundant protein in the bloodstream. Because albumin circulates for a long time and protects bound molecules from enzymatic breakdown, attaching DAC to CJC-1295 extends its functional half-life from minutes to approximately 6 to 8 days. This is highly unusual for a peptide compound and makes it one of the longest-acting GH secretagogues studied in research.

What Research Shows About Sustained GH Elevation

The extended half-life of CJC-1295 with DAC means that a single administration in a research model produces a prolonged elevation of growth hormone levels rather than a brief spike. Research has documented:

• Sustained GH pulse amplification: Studies show CJC-1295 with DAC increases baseline GH levels and amplifies pulsatile GH release over the course of days, not hours.
• IGF-1 elevation: Research consistently shows corresponding elevations in IGF-1 (insulin-like growth factor 1), the primary downstream mediator of GH’s anabolic and tissue-building effects.
• Fat metabolism: Studies in animal models have shown increased lipolysis (fat breakdown) under sustained GH elevation, making CJC-1295 with DAC useful in body composition research.
• Protein synthesis markers: Research suggests sustained GH elevation promotes nitrogen retention and protein synthesis, relevant to muscle and tissue research.

How CJC-1295 with DAC Differs from CJC-1295 No DAC

This distinction matters a great deal in research protocol design. CJC-1295 No DAC (also called Modified GRF 1-29 or Mod GRF) has a half-life of roughly 30 minutes. It produces a shorter, more natural GH pulse that more closely mimics the body’s own pulsatile GH release pattern.

Researchers choose between the two based on what they’re trying to study:

• CJC-1295 No DAC is preferred for studies examining pulsatile GH dynamics, circadian GH rhythm research, or protocols requiring multiple precisely timed observations.
• CJC-1295 with DAC is preferred when researchers want to study the effects of sustained, elevated GH over days — for instance, in longer-term body composition or tissue repair studies where consistent GH exposure is the variable of interest.

The two compounds are not interchangeable in research design — the half-life difference is too significant and changes the physiological model fundamentally.

Research Applications in Endocrinology and Aging

CJC-1295 with DAC has found particular interest in aging and age-related decline research. GH secretion naturally declines with age (a phenomenon called somatopause), and researchers studying this decline use compounds like CJC-1295 with DAC to model what restored GH signaling might look like over extended periods in animal models. This has implications for research into muscle loss, fat accumulation, and metabolic changes associated with aging.

Order CJC-1295 with DAC for Your Research Lab

PeptiVigor offers CJC-1295 5mg for qualified research applications. Each batch is produced to high purity standards appropriate for laboratory use.

Explore our full GH secretagogue catalog at peptivigor.com. Use code LABVIP1 at checkout to save 15% off your order.